Table 1.
Characteristics and finding | n = 172 |
---|---|
Age (years old) | 63.53 (38-83) |
Tumor size (cm) | 3.81 (1-8.5) |
Gender | |
Male | 129 (75) |
Female | 43 (25) |
Race | |
Han | 94 (54.7) |
Kazak | 78 (45.3) |
Tumor site | |
Upper | 8 (4.7) |
Middle | 95 (55.2) |
Lower | 69 (40.1) |
Differentiation | |
Well | 33 (19.2) |
Moderate | 97 (56.4) |
Poor | 42 (24.4) |
pTNM | |
IB | 12 (7) |
IIA,B | 86 (50) |
IIIA,B,C | 74 (43) |
Lymph metastasis | |
Negative | 113 (65.7) |
Positive | 59 (34.3) |
Vessel invasion | |
Negative | 141 (82) |
Positive | 31 (18) |
Nerve invasion | |
Negative | 136 (79.1) |
Positive | 36 (20.9) |
Distant metastases | |
Negative | 132 (76.7) |
Positive | 40 (23.3) |
Treatment | |
Surgery | 109 (63.4) |
Postoperative chemoradiotherapy | 63 (36.6) |
FGF2 | |
Low expression | 55 (32) |
High expression | 117 (68) |
FGFR3 | |
Low expression | 61 (35.5) |
High expression | 111 (64.5) |
FGFBP1 | |
Low expression | 60 (34.9) |
High expression | 112 (65.1) |